Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pedersen-Bjergaard

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Leukemia|February 15, 2008
NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic featuresM T Andersen, M K Andersen, D H Christiansen, et al.
Acta Medica Scandinavica|January 1, 1980
Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agentsJ Pedersen-Bjergaard, M M Hansen, C H Geisler, et al.
American Journal of Hematology|April 1, 1985
Acute nonlymphocytic leukemia following treatment of testicular cancer and gastric cancer with combination chemotherapy not including alkylating agents: report of two casesJ Pedersen-Bjergaard, M Rørth, S Avnstrøm, et al.
European Journal of Haematology|July 1, 1989
Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's diseaseB Frederiksen, L Specht, J Henrichsen, et al.
Leukemia|November 30, 2012
IDH1 and IDH2 mutations in therapy-related myelodysplastic syndrome and acute myeloid leukemia are associated with a normal karyotype and with der(1;7)(q10;p10)M K Westman, J Pedersen-Bjergaard, M T Andersen, et al.
Genes, Chromosomes & Cancer|November 21, 1998
Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive casesJ Pedersen-Bjergaard, S Timshel, M K Andersen, et al.
Scandinavian Journal of Haematology|September 1, 1978
Chronic lymphocytic leukaemia with subsequent development of multiple myeloma. Evidence of two B-lymphocyte clones and of myeloma-induced suppression of secretion of an M-component and of normal immunoglobulinsJ Pedersen-Bjergaard, H D Petersen, M Thomsen, et al.
Cancer Research|April 1, 1988
Point mutation of the ras protooncogenes and chromosome aberrations in acute nonlymphocytic leukemia and preleukemia related to therapy with alkylating agentsJ Pedersen-Bjergaard, W G Janssen, J Lyons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
Therapy-related acute nonlymphocytic leukemia of FAB type M4 or M5 with early onset and t(9;11) (p21;q23) or a normal karyotype: a separate entity?J Pedersen-Bjergaard, P Philip, V Ravn, et al.
Cancer Treatment Reports|July 1, 1978
Clinical trial of rubidazone in solid tumors and malignant lymphomasT Skovsgaard, H H Hansen, H T Mouridsen, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Leukemia|February 15, 2008
NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic featuresM T Andersen, M K Andersen, D H Christiansen, et al.
Acta Medica Scandinavica|January 1, 1980
Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agentsJ Pedersen-Bjergaard, M M Hansen, C H Geisler, et al.
American Journal of Hematology|April 1, 1985
Acute nonlymphocytic leukemia following treatment of testicular cancer and gastric cancer with combination chemotherapy not including alkylating agents: report of two casesJ Pedersen-Bjergaard, M Rørth, S Avnstrøm, et al.
European Journal of Haematology|July 1, 1989
Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's diseaseB Frederiksen, L Specht, J Henrichsen, et al.
Leukemia|November 30, 2012
IDH1 and IDH2 mutations in therapy-related myelodysplastic syndrome and acute myeloid leukemia are associated with a normal karyotype and with der(1;7)(q10;p10)M K Westman, J Pedersen-Bjergaard, M T Andersen, et al.
Genes, Chromosomes & Cancer|November 21, 1998
Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive casesJ Pedersen-Bjergaard, S Timshel, M K Andersen, et al.
Scandinavian Journal of Haematology|September 1, 1978
Chronic lymphocytic leukaemia with subsequent development of multiple myeloma. Evidence of two B-lymphocyte clones and of myeloma-induced suppression of secretion of an M-component and of normal immunoglobulinsJ Pedersen-Bjergaard, H D Petersen, M Thomsen, et al.
Cancer Research|April 1, 1988
Point mutation of the ras protooncogenes and chromosome aberrations in acute nonlymphocytic leukemia and preleukemia related to therapy with alkylating agentsJ Pedersen-Bjergaard, W G Janssen, J Lyons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
Therapy-related acute nonlymphocytic leukemia of FAB type M4 or M5 with early onset and t(9;11) (p21;q23) or a normal karyotype: a separate entity?J Pedersen-Bjergaard, P Philip, V Ravn, et al.
Cancer Treatment Reports|July 1, 1978
Clinical trial of rubidazone in solid tumors and malignant lymphomasT Skovsgaard, H H Hansen, H T Mouridsen, et al.
Pageof 10